"What is jealousy but a reflection of your own failures?" - Michael Connelly, The Last Coyote
Today we revisit Strongbridge Biopharma (SBBP). This small-cap biotech stock rallied last week as several analyst firms reiterated Buy ratings to the stock.
Despite last week's rally, the stock is still significantly below where drug giant Novo Nordisk (NVO) took a substantial equity stake in Strongbridge late last year. Let's take an updated view on this promising biotech concern.
Company Overview:
This New York-based biopharmaceutical company is focused on building up a franchise to